The Current Ratio as of December 2024 (TTM) for Assertio Holdings, Inc. (ASRT) is 2.01

According to Assertio Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.01. This represents a change of 5.32% compared to the average of 1.91 of the last 4 quarters.

Assertio Holdings, Inc. (ASRT) Historical Current Ratio (quarterly & annually)

How has ASRT Current Ratio performed in the past?

The mean historical Current Ratio of Assertio Holdings, Inc. over the last ten years is 2.28. The current 2.01 Current Ratio has changed 8.71% with respect to the historical average. Over the past ten years (40 quarters), ASRT's Current Ratio was at its highest in in the December 2014 quarter at 11.81. The Current Ratio was at its lowest in in the December 2019 quarter at 0.56.

Assertio Holdings, Inc. (ASRT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Assertio Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Assertio Holdings, Inc. (ASRT) Average Current Ratio

How has ASRT Current Ratio performed in the past?

The current Current Ratio of Assertio Holdings, Inc. (ASRT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Assertio Holdings, Inc. (ASRT) Current Ratio vs. Peers

How is ASRT’s Current Ratio compared to its peers?

Assertio Holdings, Inc.’s Current Ratio is greater than Agile Therapeutics, Inc. (0.55), greater than Amneal Pharmaceuticals, Inc. (1.38), less than AcelRx Pharmaceuticals, Inc. (4.42), greater than Lifecore Biomedical, Inc. (1.83), less than Ironwood Pharmaceuticals, Inc. (3.62), less than Neurocrine Biosciences, Inc. (4.37), less than Deciphera Pharmaceuticals, Inc. (4.19), greater than Esperion Therapeutics, Inc. (1.85), less than ANI Pharmaceuticals, Inc. (2.74), less than Alkermes plc (3.45), greater than Dr. Reddy's Laboratories Limited (1.92), greater than Collegium Pharmaceutical, Inc. (0.97), less than Pacira BioSciences, Inc. (2.25), less than Intra-Cellular Therapies, Inc. (7.66), less than Catalent, Inc. (2.51), less than Amphastar Pharmaceuticals, Inc. (3.43), less than Alvotech (2.69), greater than Eagle Pharmaceuticals, Inc. (1.70), less than Evolus, Inc. (2.47),

Build a custom stock screener for Assertio Holdings, Inc. (ASRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assertio Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Assertio Holdings, Inc. (ASRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Assertio Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.